A RANDOMIZED PHASE 2 STUDY OF ERLOTINIB PLUS PEMETREXED VS ERLOTINIB OR PEMETREXED ALONE AS SECOND-LINE TREATMENT FOR NEVER-SMOKER PATIENTS WITH NON-SQUAMOUS ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Lee, D. H. [1 ]
Lee, J. S. [1 ]
Kim, S. W. [1 ]
Rodrigues Pereira, J. [2 ]
Han, B. [3 ]
Song, X. Q. [4 ]
Wang, J. [5 ]
Kim, H-K. [6 ]
Sahoo, T. P. [7 ]
Digumarti, R. [8 ]
Wang, X. [9 ]
Altug, S. [10 ]
Orlando, M. [11 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Grp Assistencia Med, Sao Paulo, Brazil
[3] Shanghai Chest Hosp, Shanghai, Peoples R China
[4] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Peoples R China
[5] Beijing Tumor Hosp, Beijing, Peoples R China
[6] St Vincent Hosp, Suwon, South Korea
[7] Chirayu Med Coll & Hosp, Bhopal, India
[8] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India
[9] Eli Lilly & Co, Shanghai, Peoples R China
[10] Eli Lilly & Co, Istanbul, Turkey
[11] Eli Lilly & Co, Buenos Aires, DF, Argentina
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [41] A retrospective study of maintenance pemetrexed in advanced non-squamous non-small cell lung cancer
    Oguh, L.
    Ranatunge, D.
    Lind, M.
    Ukadhyay, S.
    El-Mahdawi, N.
    [J]. LUNG CANCER, 2018, 115 : S30 - S30
  • [42] Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis
    Fragoulakis, V. F.
    Pallis, A. G.
    Kaitelidou, D. K.
    Maniadakis, N. M.
    Georgoulias, V. G.
    [J]. LUNG CANCER-TARGETS AND THERAPY, 2012, 3 : 43 - 51
  • [43] Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321
    Kasai, Takashi
    Mori, Kiyoshi
    Nakamura, Yoichi
    Seki, Nobuhiko
    Ichikawa, Yasuko
    Saito, Haruhiro
    Kondo, Tetsuro
    Nishikawa, Kazuo
    Otsu, Satoshi
    Bessho, Akihiro
    Tanaka, Hiroshi
    Yamaguchi, Hiroyuki
    Kaburagi, Takayuki
    Imai, Hisao
    Mori, Keita
    Ohtake, Junya
    Okamoto, Hiroaki
    [J]. CANCER MEDICINE, 2023, 12 (14): : 14988 - 14999
  • [44] Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-na⟨ve advanced non-squamous non-small cell lung cancer with EGFR mutations
    Tamiya, Motohiro
    Tamiya, Akihiro
    Shiroyama, Takayuki
    Takeoka, Sawa
    Naito, Yujiro
    Omachi, Naoki
    Kimura, Yohei
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Atagi, Shinji
    Hirashima, Tomonori
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 608 - 614
  • [45] Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations
    Motohiro Tamiya
    Akihiro Tamiya
    Takayuki Shiroyama
    Sawa Takeoka
    Yujiro Naito
    Naoki Omachi
    Yohei Kimura
    Naoko Morishita
    Hidekazu Suzuki
    Norio Okamoto
    Kyoichi Okishio
    Tomoya Kawaguchi
    Shinji Atagi
    Tomonori Hirashima
    [J]. Investigational New Drugs, 2018, 36 : 608 - 614
  • [46] Clinical Study of Pemetrexed as the First-line Treatment in Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Pu Xiaolin
    Wang Jun
    Li Wei
    Lu Binbin
    Wang Zhaoxia
    Yang Min
    Fan Weifei
    [J]. JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 205 - 209
  • [47] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [48] Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
    Gonzalez, P.
    Ortega-Joaquin, N.
    Provencio Pulla, M.
    Garrido, C.
    Echave, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [49] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [50] PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)
    Ganju, Vinod
    Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae-Ho
    Wang, Jie
    Martinez, Luis
    Barraclough, Helen
    Van Kooten, Maximiliano
    Orlando, Mauro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S417 - S418
12345